Use FACS sorting in metabolic engineering of escherichia coli for increased peptide production

Methods in Molecular Biology

Volumn 834, Issue , 2012, Pages 177-196

  Cheng, Qiong ^a   Ruebling Jass, Kristin ^a   Zhang, Jianzhong ^a   Chen, Qi ^a   Croker, Kevin M ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Amino acid synthesis; Fluorescence activated cell sorting; Inclusion body; Lumio labeling; Metabolic engineering; Peptide production

Indexed keywords

PEPTIDE;

ARTICLE; DNA SEQUENCE; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE LIBRARY; GENETICS; METABOLIC ENGINEERING; METABOLISM; METHODOLOGY; PLASMID; STAINING;

ESCHERICHIA COLI; FLOW CYTOMETRY; GENOMIC LIBRARY; METABOLIC ENGINEERING; PEPTIDES; PLASMIDS; SEQUENCE ANALYSIS, DNA; STAINING AND LABELING;

ESCHERICHIA COLI;

EID: 84862926040     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-483-4_12     Document Type: Article

References (15)

1. Herzenberg LA, Parks D, Sahaf B et al (2002) The history and future of the fl uorescence activated cell sorter and fl ow cytometry: A view from Stanford. Clinical Chemistry 48:1819-27.
2. Tracy BP, Gaida SM, Papoutsakis ET (2010) Flow cytometry for bacteria: enabling metabolic engineering, synthetic biology and the elucidation of complex phenotypes. Curr Opinion in Biotechnol 21:85-99.
3. Mattanovich D, Borth N (2006) Applications of cell sorting in biotechnology. Review. Microb Cell Fact 5:12-22.
4. Nebe-von-Caron G, Stephens PJ, Hewitt CJ et al (2000) Analysis of bacterial function by multicolour fl uorescence fl ow cytometry and single cell sorting. J Microbiol Methods 42:97-114.
5. Johnson IS (1983) Human insulin from recombinant DNA technology. Science 219:632-7. (Pubitemid 13185414)
6. Brassard DL, Grace MJ, Bordens RW (2002) Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol 71:565-81.
7. Stübgen JP (2009) Recombinant interferonbeta therapy and neuromuscular disorders. J Neuroimmunol 212:132-41.
8. Ng T, Marx G, Littlewood T, Macdougal LI (2003) Recombinant erythropoietin in clinical practice. Postgrad Med J 79:367-76. (Pubitemid 36993965)
9. Maurer KH (2004) Detergent proteases. Curr Opin Biotechnol 15:330-4.
10. Misawa S, Kumagai I (1999) Refolding of therapeutic proteins in Escherichia coli as inclusion bodies. Biopolymers 51:297-307. (Pubitemid 30014252)
11. Fischer B, Sumner I, Goodenough P (1993) Isolation, renaturation, and formation of disulfi de bonds of enkaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnol Bioeng 41:3-13. (Pubitemid 23004914)
12. Griffin BA, Adams SR, Jones J, Tsien RY (1998) Specifi c covalent labeling of recombinant protein molecules inside live cells. Science 281: 269-72. (Pubitemid 28334512)
13. Adams SR, Campbell RE et al (2002) New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: Synthesis and biological applications. J AM Chem Soc 124:6063-76. (Pubitemid 34552852)
14. Berry A (1996) Improving production of aromatic compounds in Escherichia coli by metabolic engineering. Trends Biotechnol 14: 250-6.
15. Hayzer DJ, Leisinger T (1980) The geneenzyme relationships of proline biosynthesis in Escherichia coli . J Gen Microbiol 118: 287-93. (Pubitemid 10012984)